Title:	Development of recombinant vaccine against tick fever disease based on chimeric protein of Babesia sp and Anaplasma marginale associated with nanoparticles adjuvants.
Authors:	GASPAR, E. B. SANTOS, L. R. dos ARAUJO, F. R. GULIAS-GOMES, C. C. LINCOPAN, N. BRANDAO, H. de M. ROSINHA, G. M. S.
Affiliation:	EMANUELLE BALDO GASPAR, CPPSUL; LENITA RAMIRES DOS SANTOS, CNPGC; FLABIO RIBEIRO ARAUJO, CNPGC; CLAUDIA CRISTINA GULIAS GOMES, CPPSUL; N. LINCOPAN, USP; HUMBERTO DE MELLO BRANDAO, CNPGL; GRACIA MARIA SOARES ROSINHA, CNPGC.
Date Issued:	2012
Citation:	In: SIMPÓSIO EMBRAPA LABEX EUA DE SANIDADE ANIMAL, 2., 2012, Brasília, DF. Anais... Brasília, DF: Embrapa Estudos e Capacitação, 2012.
Pages:	p. 153.
Description:	This project aims the development of a new vaccine against babesiosis and anaplasmosis based on a chimeric protein and new adjuvants. A chimeric protein formed by Anaplasma marginale VirB9 and Virb10 protein and B. bigemina PO protein will be constructed by genetic engineering.
Thesagro:	Anaplasmose Babesiose Vacina
Type of Material:	Resumo em anais e proceedings
Access:	openAccess
Appears in Collections:	Resumo em anais de congresso (CNPGL)